Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KB.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KB.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KB.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CJ.1.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CJ.1.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CJ.1.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XANORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XANENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XANENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XANNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.53ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.53NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EU.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EU.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EU.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EU.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HU.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used